You are here

Hyphens inks MOU with A*Star's A*ccelerate

The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders


SGX Catalist-listed Hyphens Pharma International Limited signed a Memorendum of Understanding (MOU) with A*Star's commercial arm A*ccelerate, previously known as Exploit Technologies, at the opening ceremony of its corporate headquarters and integrated facility in Singapore on...

Market voices on: